Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1...
Hence then, the article about hanmi secures export deal with mexican partner sanfer for glp 1 obesity drug and more was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More )
Also on site :
- One-third of Seattle’s downtown is empty: Here’s how America’s boomtown turned into one of the toughest places to find a job
- Benedict Cumberbatch, Alan Cumming, Benedict Wong Pen Op-Ed Urging U.K. to Block “Dangerous” Paramount-Warner Bros. Merger
- Toyota Motor Corporation, Volvo Group and Daimler Truck have signed binding agreement for Toyota to join cellcentric as equal shareholder